Wednesday, October 19, 2011

Cancer drug Rituximab/Rituxan-study in ME/CFS in PLoS ONE: major improvements in all symptoms in 67 % of patients

There were no serious adverse events. Read more>>

1 comment:

Anonymous said...

hopefully this works...

http://translate.googleusercontent.com/translate_c?hl=en&ie=UTF8&prev=_t&rurl=translate.google.co.uk&sl=no&tl=en&u=http://www.tv2.no/nyheter/innenriks/helse/spoer-meforskerne-om-gjennombruddet-3615662.html&usg=ALkJrhgVI40Jt8txDd4-XRtBAnocVXPmqQ

LinkWithin

Related Posts with Thumbnails